NAD(+) metabolism as a target for metabolic health: have we found the silver bullet?

Niels J. Connell; Riekelt H. Houtkooper; Patrick Schrauwen

doi:10.1007/s00125-019-4831-3

NAD(+) metabolism as a target for metabolic health: have we found the silver bullet?

Niels J. Connell, Riekelt H. Houtkooper, Patrick Schrauwen^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › Academic › peer-review

Original language	English
Pages (from-to)	888-899
Number of pages	12
Journal	Diabetologia
Volume	62
Issue number	6
DOIs	https://doi.org/10.1007/s00125-019-4831-3
Publication status	Published - Jun 2019

Keywords

Diabetes
Energy metabolism
Human
Metabolic disease
NAD(+)
Review
FATTY LIVER-DISEASE
SKELETAL-MUSCLE
NICOTINIC-ACID
MITOCHONDRIAL-FUNCTION
THERAPEUTIC TARGET
INSULIN-RESISTANCE
SIRT1
IMPROVES
EXERCISE
PHARMACOKINETICS

Access to Document

10.1007/s00125-019-4831-3

Cite this

Connell, N. J., Houtkooper, R. H., & Schrauwen, P. (2019). NAD(+) metabolism as a target for metabolic health: have we found the silver bullet? Diabetologia, 62(6), 888-899. https://doi.org/10.1007/s00125-019-4831-3

@article{6441189351c4477ba7a444dd5c89499d,

title = "NAD(+) metabolism as a target for metabolic health: have we found the silver bullet?",

keywords = "Diabetes, Energy metabolism, Human, Metabolic disease, NAD(+), Review, FATTY LIVER-DISEASE, SKELETAL-MUSCLE, NICOTINIC-ACID, MITOCHONDRIAL-FUNCTION, THERAPEUTIC TARGET, INSULIN-RESISTANCE, SIRT1, IMPROVES, EXERCISE, PHARMACOKINETICS",

author = "Connell, {Niels J.} and Houtkooper, {Riekelt H.} and Patrick Schrauwen",

year = "2019",

month = jun,

doi = "10.1007/s00125-019-4831-3",

language = "English",

volume = "62",

pages = "888--899",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer, Cham",

number = "6",

}

TY - JOUR

T1 - NAD(+) metabolism as a target for metabolic health

T2 - have we found the silver bullet?

AU - Connell, Niels J.

AU - Houtkooper, Riekelt H.

AU - Schrauwen, Patrick

PY - 2019/6

Y1 - 2019/6

KW - Diabetes

KW - Energy metabolism

KW - Human

KW - Metabolic disease

KW - NAD(+)

KW - Review

KW - FATTY LIVER-DISEASE

KW - SKELETAL-MUSCLE

KW - NICOTINIC-ACID

KW - MITOCHONDRIAL-FUNCTION

KW - THERAPEUTIC TARGET

KW - INSULIN-RESISTANCE

KW - SIRT1

KW - IMPROVES

KW - EXERCISE

KW - PHARMACOKINETICS

U2 - 10.1007/s00125-019-4831-3

DO - 10.1007/s00125-019-4831-3

M3 - Review article

VL - 62

SP - 888

EP - 899

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 6

ER -